Protalix Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.22

-0.14 (-5.93%)

As of Aug 16, 10:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +1,305.9% upside

Low Target $17.92

Average Target $31.21

High Target $31.70

Current Price $2.22

Current
$2.22

Target
$31.21

$17.92 $31.21 avg $31.70

Scenario Analysis

Bear Case

$17.92

707.2%

Low target

Base Case

$31.21

+1,305.9%

Avg target

Bull Case

$31.70

+1,327.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.19

-30.4% from high

52-Week Low

$1.46

+52.1% from low

Target vs 52W High

$31.21

+878.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-0.5%
AMGN Amgen Inc	Hold	43	49%	$190.87	-55.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+152.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-17.0%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-54.1%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-47.2%
BIIB Biogen Inc	Buy	43	67%	$91.45	-57.0%